Gongdong Medical announced that the company plans to acquire 55% of the equity of Urumqi Jindongsheng Trading Co., Ltd. through equity transfer, with an investment amount of 45.65 million yuan, corresponding to a registered capital of 5.5 million yuan. This investment does not involve related party transactions and does not constitute a major asset restructuring. It has been approved by the board of directors and does not require submission to the shareholders' meeting for approval. After the investment is completed, Jindongsheng will become a wholly-owned subsidiary of the company. In 2023, Jindongsheng's operating income was 66.4261 million yuan, with a net profit of 13.9091 million yuan; from January to September 2024, the operating income was 45.3744 million yuan, with a net profit of 10.0646 million yuan